Carl J DeSelm

7PUBLICATIONS
106CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2026
Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

|Jul 02, 2025
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

Tianyi Liu, Meng Zhang, Tatyanah Farsh

|Aug 09, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer.

Miriam T Jacobs, Pamela Wong, Alice Y Zhou

|Apr 24, 2023
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation.

Alexander B Kim, Ssu-Yu Chou, Solomon Kang

|Mar 08, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.

Douglas V Faget, Xianmin Luo, Matthew J Inkman

|Aug 10, 2021
The Current and Future Role of Radiation Therapy in the Era of CAR T-cell Salvage.

Carl DeSelm

Pageof 2

Frequent Collaborators

2 joint publications

Alexander B Kim

2 joint publications

Jin Zhang

2 joint publications

Matthew J Inkman

1 joint publications

Qiankun Wang